Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia (Q33734735)

29 July 2017

title

Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia (English)

1 reference

29 July 2017

main subject

lymphoblastic leukemia

1 reference

Kanerva J

1

1 reference

29 July 2017

Saarinen-Pihkala UM

2

1 reference

29 July 2017

Riikonen P

3

1 reference

29 July 2017

Mäkipernaa A

4

1 reference

29 July 2017

Möttönen M

5

1 reference

29 July 2017

Salmi TT

6

1 reference

29 July 2017

publication date

1 October 1999

1 reference

29 July 2017

published in

Pediatric Blood & Cancer

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

388-394

1 reference

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Multiple Drug Resistance Mediated by P-Glycoprotein is not a Major Factor in a Slow Response to Therapy in Childhood All

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Variable detection of myeloid antigens in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

The French-American-British (FAB) classification of leukemia. The Pediatric Oncology Group experience with lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

Detection of the chromosomally abnormal clone in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

10.1002/(SICI)1096-911X(199910)33:4<388::AID-MPO8>3.0.CO;2-N

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference